000 01566 a2200445 4500
005 20250516074716.0
264 0 _c20120628
008 201206s 0 0 eng d
022 _a1098-6596
024 7 _a10.1128/AAC.05838-11
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJeannot, Katy
245 0 0 _aIMP-29, a novel IMP-type metallo-β-lactamase in Pseudomonas aeruginosa.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cApr 2012
300 _a2187-90 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aCarbapenems
_xmetabolism
650 0 4 _aDNA, Bacterial
_xgenetics
650 0 4 _aEscherichia coli
_xdrug effects
650 0 4 _aFatal Outcome
650 0 4 _aHumans
650 0 4 _aHydrolysis
650 0 4 _aIntegrons
_xgenetics
650 0 4 _aMale
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aPseudomonas Infections
_xdrug therapy
650 0 4 _aPseudomonas aeruginosa
_xenzymology
650 0 4 _aShock, Septic
_xdrug therapy
650 0 4 _abeta-Lactamases
_xgenetics
700 1 _aPoirel, Laurent
700 1 _aRobert-Nicoud, Marjorie
700 1 _aCholley, Pascal
700 1 _aNordmann, Patrice
700 1 _aPlésiat, Patrick
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 56
_gno. 4
_gp. 2187-90
856 4 0 _uhttps://doi.org/10.1128/AAC.05838-11
_zAvailable from publisher's website
999 _c21504183
_d21504183